|
CREB5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.401540E-04 |
| Normal-vs-Stage3 |
4.61169999999012E-06 |
| Normal-vs-Stage4 |
3.60950000000138E-05 |
| Stage1-vs-Stage2 |
8.162200E-01 |
| Stage1-vs-Stage3 |
1.344370E-01 |
| Stage1-vs-Stage4 |
4.484300E-03 |
| Stage2-vs-Stage3 |
2.186000E-01 |
| Stage2-vs-Stage4 |
9.811700E-02 |
| Stage3-vs-Stage4 |
5.269400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.51241258300661E-12 |
| Normal-vs-Asian |
8.109600E-02 |
| Caucasian-vs-AfricanAmerican |
5.588200E-01 |
| Caucasian-vs-Asian |
4.822000E-01 |
| AfricanAmerican-vs-Asian |
4.371800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.84185999785313E-13 |
| Male-vs-Female |
5.772600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.80170000930025E-09 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
4.54125625992674E-12 |
| Normal-vs-Extreme_Obese |
4.904300E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.107840E-01 |
| Normal_Weight-vs-Obese |
2.482100E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.143600E-01 |
| Extreme_Weight-vs-Obese |
3.033800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.846800E-01 |
| Obese-vs-Extreme_Obese |
8.519600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.59570000000309E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
5.036300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.918400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.699600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.067180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.768300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.544200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.978000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.00410000314355E-08 |
| Normal-VS-KIRP CIMP |
2.007900E-02 |
| Normal-VS-Unclassified PRCC |
1.36480000001438E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.41459963135071E-10 |
| Type1 PRCC-VS-KIRP CIMP |
2.910400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.248800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.637800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.628040E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.742800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.18500004148348E-09 |
| Normal-vs-N1 |
5.38929999960303E-07 |
| Normal-vs-N2 |
8.245800E-02 |
| N0-vs-N1 |
7.010000E-01 |
| N0-vs-N2 |
4.151600E-01 |
| N1-vs-N2 |
2.383800E-01 |
|
|
